BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29016636)

  • 1. Expression of ribosomal proteins in normal and cancerous human prostate tissue.
    Arthurs C; Murtaza BN; Thomson C; Dickens K; Henrique R; Patel HRH; Beltran M; Millar M; Thrasivoulou C; Ahmed A
    PLoS One; 2017; 12(10):e0186047. PubMed ID: 29016636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
    Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
    Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder.
    Choesmel V; Fribourg S; Aguissa-Touré AH; Pinaud N; Legrand P; Gazda HT; Gleizes PE
    Hum Mol Genet; 2008 May; 17(9):1253-63. PubMed ID: 18230666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue.
    Symes AJ; Eilertsen M; Millar M; Nariculam J; Freeman A; Notara M; Feneley MR; Patel HR; Masters JR; Ahmed A
    PLoS One; 2013; 8(12):e84295. PubMed ID: 24386364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages.
    Wang Q; Zhang JG; Wang W
    Genet Mol Res; 2015 Jun; 14(2):6844-51. PubMed ID: 26125892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of CD147 protein in prostate cancer].
    He HC; Han ZD; Dai QS; Zou J; Zhang Y; Zhang Z; Liang YX; Ye YK; Chen ZN; Zhong WD
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1844-6. PubMed ID: 19953931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomal protein l19 is a prognostic marker for human prostate cancer.
    Bee A; Ke Y; Forootan S; Lin K; Beesley C; Forrest SE; Foster CS
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2061-5. PubMed ID: 16609016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer.
    Mohsenzadegan M; Shekarabi M; Madjd Z; Asgari M; Abolhasani M; Tajik N; Farajollahi MM
    Biomark Med; 2015; 9(4):391-401. PubMed ID: 25808443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates.
    Väänänen RM; Ochoa NT; Boström PJ; Taimen P; Pettersson K
    BMC Urol; 2015 Aug; 15():88. PubMed ID: 26294063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the interactome of ribosomal protein S19 mutants.
    Caterino M; Aspesi A; Pavesi E; Imperlini E; Pagnozzi D; Ingenito L; Santoro C; Dianzani I; Ruoppolo M
    Proteomics; 2014 Oct; 14(20):2286-96. PubMed ID: 25069755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.
    Adamo HH; Halin Bergström S; Bergh A
    PLoS One; 2015; 10(6):e0130076. PubMed ID: 26076453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.
    Grupp K; Diebel F; Sirma H; Simon R; Breitmeyer K; Steurer S; Hube-Magg C; Prien K; Pham T; Weigand P; Michl U; Heinzer H; Kluth M; Minner S; Tsourlakis MC; Izbicki JR; Sauter G; Schlomm T; Wilczak W
    Prostate; 2013 Nov; 73(15):1690-8. PubMed ID: 23843146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing.
    Ma X; Guo J; Liu K; Chen L; Liu D; Dong S; Xia J; Long Q; Yue Y; Zhao P; Hu F; Xiao Z; Pan X; Xiao K; Cheng Z; Ke Z; Chen ZS; Zou C
    Mol Cancer; 2020 Oct; 19(1):147. PubMed ID: 33032611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
    Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
    Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.
    Weigle B; Kiessling A; Ebner R; Fuessel S; Temme A; Meye A; Schmitz M; Rieger MA; Ockert D; Wirth MP; Rieber EP
    Int J Cancer; 2004 May; 109(6):882-92. PubMed ID: 15027122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.